Coherus BioSciences, Inc. (CHRS) Social Stream



Coherus BioSciences, Inc. (CHRS): $7.50

0.11 (+1.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CHRS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

Featured Post From StockTwits About CHRS

$CHRS pretty confused with the price action...
The price seems Go up with no regard to the indices or macro news.
This was proven today

Honestly think we Will bê close to all time highs(30 USD) this year if this happens:
- adalimumab is aprroved
-lucentis is accepted
-tori New data is positive
- beva phase 3 has good results (maybe only in Q1 of 2022).

So many catalyts ranging from data readouts to BLA fillings, the only danger is management themselves
Stonks2022, published August 16, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3847 seconds.